Disease control coincided with the increase and lasting expansion of leukemia-specific CD8+ and CD4+ T lymphocytes, specifically WT1, MUC1, and NY-ESO antigens in patients with HLA-A *0201 [93], Clinicaltrials.gov NCT01096602, Table 2. This evidence concerns the gene WT1 and leukemia.